However, previous studies showing that BSSL knockout mice are almost completely protected from developing collagen induced arthritis, and that anti-BSSL antibodies can be used to mitigate disease severity in mice and rat arthritis models [15] clearly supports the first alternative and thus point out BSSL as an exciting novel potential target for new anti-inflammatory drugs. This evidence concerns the gene CEL and Arthritis.